Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US10695328B2
公开(公告)日:2020-06-30
The present invention provides compounds of Formula (I):
or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.
ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20190314346A1
公开(公告)日:2019-10-17
The present invention provides compounds of Formula (I):
or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.
US9663466B2
申请人:——
公开号:US9663466B2
公开(公告)日:2017-05-30
Direct oxidative amidation between methylarenes and amines in water